Search company, investor...

nContact Surgical

ncontact.us

Founded Year

2005

Stage

Acquired | Acquired

Total Raised

$47.9M

Valuation

$0000 

About nContact Surgical

nContact Surgical develops devices for endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris Coagulation System with VisiTrax is based on the integration of suction, perfusion, and RF energy to ensure the creation of visible, non-conducitve continuos, bi-atrail lesion on the epicardium of a beating heart.

Headquarters Location

1001 Aviation Parkway Suite 400

Morrisville, North Carolina, 27560,

United States

919-466-9810

Missing: nContact Surgical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: nContact Surgical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing nContact Surgical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

nContact Surgical is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

nContact Surgical Patents

nContact Surgical has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/27/2015

7/9/2019

Cardiac arrhythmia, Cardiac anatomy, Heart diseases, Cardiac electrophysiology, Cardiology

Grant

Application Date

2/27/2015

Grant Date

7/9/2019

Title

Related Topics

Cardiac arrhythmia, Cardiac anatomy, Heart diseases, Cardiac electrophysiology, Cardiology

Status

Grant

Latest nContact Surgical News

nContact Surgical LLC Medical Equipment Deals and Alliances Profile Report Updated 17072017 Prices from USD $250

Jul 26, 2017

nContact Surgical LLC Medical Equipment Deals and Alliances Profile [Report Updated: 17072017] Prices from USD $250 23:52 EDT 25 Jul 2017 | BioPortfolio Reports Home » Topics » Surgical treatments » Latest News » nContact Surgical LLC Medical Equipment Deals and Alliances Profile [Report Updated: 17072017] Prices from USD $250 Summary nContact Surgical LLC nContact, formerly nContact, Inc., a subsidiary of AtriCure, Inc. is a medical device company that offers surgical equipments. The company offers EPiSense, Cannula, and SUBTLE access products and contract manufacturing. Its EPiSense is a device with epicardial sensing electrodes designed to navigate epicardium of the atrium and ventricle. nContact's EPiSense products also guides coagulation device with VisiTrax that provides epicardial sensing electrodes designed to allows mapping and navigating the epicardium. The company's Cannula provides trans diaphragmatic access to the posterior of the atrium. Its products are used to perform minimally invasive ablation procedures on a beating heart without any chest incisions or ports. nContact is headquartered in Morrisville, North Carolina, the US. nContact Surgical LLC Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

nContact Surgical Frequently Asked Questions (FAQ)

  • When was nContact Surgical founded?

    nContact Surgical was founded in 2005.

  • Where is nContact Surgical's headquarters?

    nContact Surgical's headquarters is located at 1001 Aviation Parkway, Morrisville.

  • What is nContact Surgical's latest funding round?

    nContact Surgical's latest funding round is Acquired.

  • How much did nContact Surgical raise?

    nContact Surgical raised a total of $47.9M.

  • Who are the investors of nContact Surgical?

    Investors of nContact Surgical include AtriCure, Harbert Venture Partners, Finistere Ventures, InterSouth Partners, Massey Burch Capital and 7 more.

  • Who are nContact Surgical's competitors?

    Competitors of nContact Surgical include NeoChord, Tepha, Axion BioSystems, MedShape, Dune Medical Devices, TrueVision Systems, Biotricity, AirXpanders, BioSet, Small Bone Innovations and 24 more.

Compare nContact Surgical to Competitors

E
Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

T
TissueLink Medical

TissueLink Medical is a developer and distributor of medical devices that for surgical procedures. The company's technology aims to eliminate the need for multiple technologies with the potential to reduce operating room and patient recovery time by enabling precise coagulation and cutting, with no excess damage to tissue. These devices will be used in general and thoracic surgical procedures.

TransCorp Logo
TransCorp

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

F
Focal

Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.

S
SpineForm

SpineForm is developing a less invasive spinal deformity surgical treatment. SpineForm's HemiBridge is a spinal implant designed to help correct and straighten spinal deformities in growing children, without the need for a brace or extensive future spinal fusion surgeries.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.